Literature DB >> 30053479

Effect of Community Screening on the Demographic Makeup and Clinical Severity of Glaucoma Patients Receiving Care in Urban China.

Yuanbo Liang1, Junhong Jiang2, Wen Ou3, Xianyao Peng2, Ruizhu Sun3, Xiang Xu3, Juanyuan Yang3, Cheng Hu3, Cong Ye3, Nathan Congdon4, Fan Lu5.   

Abstract

PURPOSE: To assess differences in clinical and demographic characteristics between glaucoma patients identified by community screening and those newly diagnosed in hospital in a Chinese setting.
DESIGN: Prospective comparative cohort study.
METHODS: A total of 373 patients identified with glaucoma among 27 000 persons undergoing community screening were enrolled as the Screening group. The Clinic group consisted of 119 consecutively presenting, newly diagnosed glaucoma patients in hospital. Primary outcomes were mean deviation (MD), visual field index (VFI) and pattern standard deviation (PSD) on Humphrey Field Analyzer, and intraocular pressure (IOP). Disease severity was categorized into 5 stages based on MD.
RESULTS: A total of 89.6% (328/373) of Screening group patients had IOP < 21 mm Hg, compared to 48.7% (58/119) in the Clinic group (P < .001). The mean VFI, MD, and PSD were 76.4% ± 23.8%, -9.7 ± 7.3 dB, and 6.4 ± 3.4 dB in the Screening group and significantly worse in the Clinic group: 44.1% ± 32.0%, -19.8 ± 9.5 dB, and 7.6 ± 3.1 dB (P < .001 for MD and VFI, P = .001 for PSD). Nearly three quarters of Screening patients had early or moderate visual field loss (monocular), while nearly half of Clinic patients had severe loss at the time of diagnosis. Screening patients were significantly more likely to be older (P < .001) and female (P < .001) than Clinic patients.
CONCLUSION: Glaucoma patients detected through community screening had significantly milder damage, and were more likely to include underserved groups (women, elderly) than those newly diagnosed in a clinic in this setting. Comparison with population studies suggests that cases of glaucoma with IOP < 21 mm Hg are severely underascertained in China, a situation that may be improved by screening.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2018        PMID: 30053479     DOI: 10.1016/j.ajo.2018.07.013

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  6 in total

1.  Visual disability among patients attending glaucoma clinic in a tertiary hospital.

Authors:  Doaa Maamoun Ashour; Mohamed Ibrahim Saleh; Mo'mena Ahmad A Awad-Allah; Randa H A Abdelgawad
Journal:  Int Ophthalmol       Date:  2021-02-02       Impact factor: 2.031

2.  Eye diseases burden in China in the past 30 years.

Authors:  Binbin Chen; Lixia Lou; Juan Ye
Journal:  Zhejiang Da Xue Xue Bao Yi Xue Ban       Date:  2021-08-25

3.  Disease Burden of Glaucoma in China: Findings from the Global Burden of Disease 2019 Study.

Authors:  Yi Sun; Aiming Chen; Minjie Zou; Zhenzhen Liu; Charlotte Aimee Young; Danying Zheng; Guangming Jin
Journal:  Clin Epidemiol       Date:  2022-07-04       Impact factor: 5.814

4.  Intraocular asymmetry of visual field defects in primary angle-closure glaucoma, high-tension glaucoma, and normal-tension glaucoma in a Chinese population.

Authors:  Junhong Jiang; Cong Ye; Cong Zhang; Wenqing Ye; Xiaoyan Wang; Xiao Shang; Xiang Xu; Hongte Zhang; Shaodan Zhang; Jingwei Zheng; Jingjing Zuo; Jingjing Hu; Nathan Congdon; Fan Lu; Yuanbo Liang
Journal:  Sci Rep       Date:  2021-06-03       Impact factor: 4.379

5.  Effect of a complex intervention to improve post-vision screening referral compliance among pre-school children in China: A cluster randomized clinical trial.

Authors:  Yangfa Zeng; Xiaotong Han; Decai Wang; Shida Chen; Yingfeng Zheng; Yuzhen Jiang; Xiang Chen; Yuting Li; Ling Jin; Qianyun Chen; Xiaoling Liang; Xiulan Zhang; Nathan Congdon; Yizhi Liu
Journal:  EClinicalMedicine       Date:  2020-02-04

6.  Design and baseline data of a population-based metabonomics study of eye diseases in eastern China: the Yueqing Ocular Diseases Investigation.

Authors:  Yuxuan Deng; Yuanbo Liang; Sigeng Lin; Liang Wen; Jin Li; Yue Zhou; Meixiao Shen; Jingwei Zheng; Kemi Feng; Yanting Sun; Kwapong Willaim Robert; Jia Qu; Fan Lu
Journal:  Eye Vis (Lond)       Date:  2020-01-19
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.